A new entrant into the U.S. medical isotope industry said Wednesday it has secured funding for construction of a 2-megawatt reactor facility for production of the medical isotope molybdenum-99.
Albuquerque, N.M.-based Eden Radioisotopes plans in four years to begin…
SUBSCRIBER ACCESS
Thank you for visiting
RadWaste Monitor!
You must be logged in as a subscriber to view this page.





